Vutrisiran

Amvuttra 25 MG Solucion Inyectable en Jeringa Precargada

25 mg solución inyectable en jeringa precargadaSpainAuthorisedAuthorised 17 Aug 2026

In other countries

The same active substances on other registers, the same brand first.

AmvuttraBrazil · Specialty Pharma Goias LtdaSame brand
AmvuttraCanada · 25 MG / 0.5 ML · Solution · Alnylam Netherlands B.V.Same brand
AmvuttraEuropean Union · Alnylam Netherlands B.V.Same brand
AmvuttraCroatiaSame brand
AmvuttraItaly · Soluzione iniettabile in siringa pre-riempita · Alnylam Netherlands BVSame brand
Amvuttra 25mg, oplossing voor injectie in voorgevulde spuitNetherlands · Oplossing voor injectie · Alnylam Netherlands B.V.Same brand
Amvuttra solution for injection in pre-filled syringe 25mgSingapore · 25mg · injection, solution · Medison Pharma Singapore Pte. LTD.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Vutrisiran

Amvuttra 25 MG Solucion Inyectable en Jeringa Precargada

25 mg solución inyectable en jeringa precargadaSpainAuthorisedAuthorised 17 Aug 2026

Product informationAsk Osler about it

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

AmvuttraUnited States · 25MG BASE/0.5ML · solution · Alnylam Pharms INC

Packs

Pack	Code	Status
AMVUTTRA 25 MG SOLUCION INYECTABLE EN JERINGA PRECARGADA, 1 jeringa precargada	771736

Documents

The official texts, at the regulator.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Agencia Española de Medicamentos y Productos Sanitarios

Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.

Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Vutrisiran
Strength: 25 mg
Dosage form: solución inyectable en jeringa precargada
Route: vía subcutánea
Register: Spain (AEMPS)
Status: Authorised
Status in the register: Autorizado, no comercializado
Authorised: 17 Aug 2026
Registration: 1221681001IP
Marketing authorisation holder: Alnylam Netherlands B.V.
Procedure: EU centralised
Supply: Uso Hospitalario